A Randomized Pharmacokinetic Study in Healthy Male Subjects Comparing a High-concentration, Citrate-free SB5 Formulation (40 mg/0.4 ml) and Prior SB5 (Adalimumab Biosimilar) - Ahn, So-shin; Lee, Minkyung; Baek, Yumin; Lee, Sukho (Rheumatology and therapy., 2022)
Keywords: Bioequivalence; Biological products; Family Medicine; General Practice; Internal Medicine; Medicine; Medicine & Public Health; Monoclonal antibodies; NCT; NCT04514796; Original Research; Orthopedics; Quality of Life Research; Rheumatology; Tumor necrosis factor-TNF; Bioequivalence; Pharmacokinetics; TNF inhibitor; Biosimilar; SB5